Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 40 min ago
PreprintAll rights reservedbioRxiv

An LRH-1 agonist reverses hepatic metabolic dysfunction in obesity

  • S. G. Mays
  • A. R. Cuevas
  • R. M. Spurlin
  • R. Polavarapu
  • C.-y. Chen
  • Z. Hou
  • M. L. Cato
  • R. Swinger
  • E. J. Millings
  • A. R. Flynn
  • D. Bhowmik
  • H. Zecca
6 more authors
  • W.-Y. Hsiao
  • S. M. Abraham
  • A. M. Johnson
  • N. T. Jui
  • E. A. Ortlund
  • J. W. Calvert1
  1. 1Emory University
Read full textPDFDOICite

Related

  1. Very low-calorie diet reduces hepatic steatosis and remodels circulating metabolite-microRNAs networks in metabolic dysfunction-associated steatotic liver disease: A pilot study
    P. Deb, D. Bagar, P. Kumar +10
    medRxivPreprintAll rights reservedFull textEndocrinology & metabolismmedRxiv
  2. Comparison of Metabolic Dysfunction‐Associated Steatotic Liver Disease Between Individuals With Werner Syndrome and Those With Insulin‐Resistant Type 2 Diabetes: Hepatic Steatosis and Fibrosis Indices
    Makoto Miyabayashi, Masaya Koshizaka, Mayumi Shoji +29
    Geriatrics & gerontology internationalPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Distinct Liver Enzyme Profiles in Non-Diabetic Obesity: Associations with Obesity Severity and Metabolic Dysfunction
    Muath Alsaidan, Daliyah M. Alruwaili, Tahani M. Alharthi +3
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Obesity, Metabolic Modulation, and Arrhythmias: From Adipose Tissue Dysfunction to a Modifiable Arrhythmogenic Substrate
    Margherita Tiezzi, Federica Valli, Andrea Mengozzi +5
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. A rare diagnosis during evaluation for metabolic dysfunction associated steatotic liver disease: Glycogen storage disease type Ia presenting during adolescence in a male with severe obesity
    Carolena Trocchia, Rachel Herdes, Jodi Gedallovich +1
    JPGN reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@misc{mays2026lrh1,
  title = {{An LRH-1 agonist reverses hepatic metabolic dysfunction in obesity}},
  author = {S. G. Mays and A. R. Cuevas and R. M. Spurlin and R. Polavarapu and C.-y. Chen and Z. Hou and M. L. Cato and R. Swinger and E. J. Millings and A. R. Flynn and D. Bhowmik and H. Zecca and W.-Y. Hsiao and S. M. Abraham and A. M. Johnson and N. T. Jui and E. A. Ortlund and J. W. Calvert},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.28.761933},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.28.761933v1},
}
RIS
TY  - UNPB
TI  - An LRH-1 agonist reverses hepatic metabolic dysfunction in obesity
AU  - S. G. Mays
AU  - A. R. Cuevas
AU  - R. M. Spurlin
AU  - R. Polavarapu
AU  - C.-y. Chen
AU  - Z. Hou
AU  - M. L. Cato
AU  - R. Swinger
AU  - E. J. Millings
AU  - A. R. Flynn
AU  - D. Bhowmik
AU  - H. Zecca
AU  - W.-Y. Hsiao
AU  - S. M. Abraham
AU  - A. M. Johnson
AU  - N. T. Jui
AU  - E. A. Ortlund
AU  - J. W. Calvert
PY  - 2026
DA  - 2026/10/28
PB  - bioRxiv
DO  - 10.64898/2026.10.28.761933
UR  - https://www.biorxiv.org/content/10.64898/2026.10.28.761933v1
ER  -